AT40963B - Process for the preparation of p-ethoxyphenylaminomethylsulphurous acid salts. - Google Patents

Process for the preparation of p-ethoxyphenylaminomethylsulphurous acid salts.

Info

Publication number
AT40963B
AT40963B AT40963DA AT40963B AT 40963 B AT40963 B AT 40963B AT 40963D A AT40963D A AT 40963DA AT 40963 B AT40963 B AT 40963B
Authority
AT
Austria
Prior art keywords
acid salts
preparation
ethoxyphenylaminomethylsulphurous
clinical trials
salts
Prior art date
Application number
Other languages
German (de)
Inventor
Roberto Dr Lepetit
Original Assignee
Roberto Dr Lepetit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roberto Dr Lepetit filed Critical Roberto Dr Lepetit
Application granted granted Critical
Publication of AT40963B publication Critical patent/AT40963B/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Description

  

   <Desc/Clms Page number 1> 
 
 EMI1.1 
 
 EMI1.2 
 

 <Desc/Clms Page number 2> 

 
 EMI2.1 
 ist. Die p-äthoxyphenylaminomethylschwefligsauren Salze, die, wie erwähnt, noch nicht be-   schrieben sind, zeichnen sich vorden bekannten #-Sulfomethylverbindungen   primärer, aromatischer Amine durch ihre therapeutische Wirksamkeit aus. An eine therapeutische Verwendung der   p-äthoxyphenylaminomethylschwefligsauren   Salze konnte erst gedacht werden, nachdem Verfahren zu ihrer Herstellung in unzersetztem Zustande gefunden war. Die bisher stets beobachtete Gelbfärbung bei Anwendung der bekannten Arbeitsweise deutete auf das Auftreten. von Zersetzungen. Für therapeutische Zwecke können aber nur reine, von   zufälligen,   in ihren 
 EMI2.2 
 bindungen benutzt werden. 



   Die mit den nach dem vorliegenden Verfahren erhältlichen   p-äthoxyphenyiaminomethyl-   schwefligsauren Salzen angestellten klinischen Versuche haben ergeben, dass die Giftigkeit des p-Phenetidins in den neuen Verbindungen unter Beibehaltung der antineuralgischen und antipyretischen Eigenschaften der freien Base stark herabgemindert ist. Die therapeutische Wirksamkeit der   p-äthoxyphenylaminometbylschwefligsauren   Salze ist umso auffallender, als nach den bisherigen Beobachtungen der Eintritt einer Säuregruppe in das   Molekül   des Antifebrins und Phenazetins eine Vernichtung der fieberstillenden Eigenschaften herbeiführt (Fränkel, "Arzneimittel-Synthese", 2. Aufl., [1906], S. 275-276).

   Die klinischen Versuche haben ergeben, dass die p-äthoxyphenylaminomethylschwefligsauren Salze im Vergleiche zum Phenazetin und Laktophenin wesentlich günstiger wirken. Auffallend ist auch, dass die Salze, wie die klinischen Versuche gezeigt haben, nicht giftig wirken.



   <Desc / Clms Page number 1>
 
 EMI1.1
 
 EMI1.2
 

 <Desc / Clms Page number 2>

 
 EMI2.1
 is. The p-ethoxyphenylaminomethylsulfuric acid salts, which, as mentioned, have not yet been described, are distinguished from the known # -sulfomethyl compounds of primary aromatic amines by their therapeutic effectiveness. A therapeutic use of the p-ethoxyphenylaminomethylsulphurous acid salts could only be considered after a method for their preparation in the undecomposed state had been found. The yellow coloration that has always been observed so far when using the known procedure indicated the occurrence. of decomposition. For therapeutic purposes, however, only pure, accidental, in their
 EMI2.2
 bindings are used.



   The clinical trials carried out with the p-ethoxyphenyiaminomethyl sulphurous acid salts obtained by the present process have shown that the toxicity of p-phenetidine in the new compounds is greatly reduced while maintaining the antineuralgic and antipyretic properties of the free base. The therapeutic effectiveness of the p-ethoxyphenylaminomethylsulfuric acid salts is all the more striking as, according to previous observations, the entry of an acid group into the molecule of antifebrin and phenacetine destroys the antipyretic properties (Fränkel, "Arzneimittel -ynthesis", 2nd ed., [1906 ], Pp. 275-276).

   The clinical trials have shown that the p-ethoxyphenylaminomethylsulfurous acid salts have a much more favorable effect compared to phenacetine and lactophenine. It is also noticeable that, as clinical trials have shown, the salts are not toxic.

 

Claims (1)

PATENT-ANSPRUCH : Verfahren zur Darstellung von p-äthoxyphenylaminomethylschwefligsauren Salzen, dadurch EMI2.3 PATENT CLAIM: Process for the preparation of p-ethoxyphenylaminomethylsulfurous acid salts, thereby EMI2.3
AT40963D 1908-09-25 1908-09-25 Process for the preparation of p-ethoxyphenylaminomethylsulphurous acid salts. AT40963B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT40963T 1908-09-25

Publications (1)

Publication Number Publication Date
AT40963B true AT40963B (en) 1910-02-10

Family

ID=3559584

Family Applications (1)

Application Number Title Priority Date Filing Date
AT40963D AT40963B (en) 1908-09-25 1908-09-25 Process for the preparation of p-ethoxyphenylaminomethylsulphurous acid salts.

Country Status (1)

Country Link
AT (1) AT40963B (en)

Similar Documents

Publication Publication Date Title
AT40963B (en) Process for the preparation of p-ethoxyphenylaminomethylsulphurous acid salts.
AT228781B (en) Process for the production of new araliphatic amines and their salts
AT228780B (en) Process for the preparation of new aromatic amines and their salts
AT59159B (en) Process for the preparation of indophenols.
DE833842C (en) Binder for foundry sand from sulphite waste liquor
AT149015B (en) Hose coupling.
AT18831B (en) Process for the preparation of calcium cyanamide.
AT54719B (en) Process for the production of plastic masses.
DE912398C (en) Process for the production of products from formaldehyde, other carbonyl compounds, ammonium salts and urea
AT253133B (en) Process for the preparation of a new sulfur-containing derivative of vitamin B6
AT273131B (en) Process for the preparation of new pyridyl-tetrahydroisoquinolines and their acid addition salts
DE895375C (en) Process for the production of solutions from mixed polyamides
AT166223B (en) Heat transfer medium for high temperatures
AT127823B (en) Process and device for the production of premium milk.
AT50274B (en) Process for the production of long-lasting solutions or soluble preparations which, in addition to iron compounds, contain quinine terbic acid or its compounds.
AT143306B (en) Precipitation hardening alloys.
AT230882B (en) Process for the production of 6-aminochryses
DE301713C (en)
AT76379B (en) Process for the production of urea superphosphate mixtures.
AT67785B (en) Process for the preparation of vaccines from pathogens.
AT236951B (en) Process for the production of new triazolidines
AT87643B (en) Process for the production of benzoic acid by the oxidation of toluene with chromosulfuric acid.
AT92324B (en) Process for accelerating the vulcanization of rubber or rubber-like substances.
AT203799B (en) Fungicides
AT52837B (en) Process for the preparation of a new compound of m-cresol with oxalic acid.